Physician profile
Daniel L Marks
NPI 1578571006
$28,469.58
in general payments reported to CMS, 2019-2025
4 companies · $63.58 in 2025
The $63.58 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,170 · 2020: $775 · 2021: $6,386 · 2022: $9,874 · 2023: $10K · 2025: $63.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $63.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,201.00 |
| Food and Beverage | $63.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24,526.00 | 2019-2023 | |
| Alkermes, INC. | $3,880.00 | 2019-2023 | |
| Abbvie INC. | $33.19 | 2025 | |
| Abbott Laboratories | $30.39 | 2025 | Ensite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.